Latest Partnerships News

Aeris Resources has outlined its FY26 production targets, aiming for a 40-49kt copper equivalent output while advancing key projects and planning asset divestments to strengthen its balance sheet.

TMK Energy has forged a strategic alliance with Beijing-based J-Energy to accelerate development planning for its Gurvantes XXXV Coal Seam Gas project in Mongolia, leveraging J-Energy’s technical expertise and Chinese market connections.

Immutep has received encouraging feedback from the FDA on its immunotherapy eftilagimod alfa combined with KEYTRUDA for patients with low PD-L1 expression in head and neck cancer, opening potential accelerated approval pathways.

SRJ Technologies has secured $1.38 million from institutional investors in a fully underwritten entitlement offer, setting the stage for a strategic joint venture and acquisition in the Middle East. The company aims to raise an additional $1.15 million through a retail offer to support its growth ambitions.

Platinum Investment Management has officially terminated its Scheme Implementation Deed with Platinum Capital Limited, marking a significant shift in the management of the Platinum International Fund Complex ETF.

Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.

Nimy Resources has appointed NYSE-listed M2i Global to spearhead its US government funding strategy, targeting key grants and loans to advance its gallium projects. This partnership aligns Nimy with critical supply chain initiatives in the United States.

Prospect Resources reports promising Phase 2 drilling results at its Mumbezhi Copper Project, revealing new strike extensions at the Nyungu Central deposit and advancing exploration across the licence.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Hot Chili Limited launches a A$14 million rights issue to fund key strategic initiatives, including advancing its La Verde copper-gold discovery and completing asset-level partnering processes within the Costa Fuego Project in Chile.